WARNINGS O
The O
potential O
for O
a O
delayed B-OSE_Labeled_AE
hypersensitivity I-OSE_Labeled_AE
reaction I-OSE_Labeled_AE
to O
fluorouracil O
exists O
. O

Patch O
testing O
to O
prove O
hypersensitivity B-NonOSE_AE
may O
be O
inconclusive O
. O

Patients O
should O
discontinue O
therapy O
with O
Carac O
if O
symptoms O
of O
DPD B-NonOSE_AE
enzyme I-NonOSE_AE
deficiency I-NonOSE_AE
develop O
. O

Rarely O
, O
unexpected O
systemic O
toxicity O
( O
e.g. O
, O
stomatitis B-NonOSE_AE
, O
diarrhea B-NonOSE_AE
, O
neutropenia B-NonOSE_AE
, O
neurotoxicity B-NonOSE_AE
) O
associated O
with O
parenteral O
administration O
of O
fluorouracil O
has O
been O
attributed O
to O
deficiency B-Not_AE_Candidate
of I-Not_AE_Candidate
dihydropyrimidine I-Not_AE_Candidate
dehydrogenase I-Not_AE_Candidate
" B-Not_AE_Candidate
DPD I-Not_AE_Candidate
" I-Not_AE_Candidate
activity O
. O

One O
case O
of O
life-threatening O
systemic O
toxicity O
has O
been O
reported O
with O
the O
topical O
use O
of O
5 O
% O
fluorouracil O
in O
a O
patient O
with O
a O
complete O
absence B-Not_AE_Candidate
of I-Not_AE_Candidate
DPD I-Not_AE_Candidate
enzyme I-Not_AE_Candidate
activity I-Not_AE_Candidate
. O

Symptoms O
included O
severe O
abdominal B-NonOSE_AE
pain I-NonOSE_AE
, O
bloody B-NonOSE_AE
diarrhea I-NonOSE_AE
, O
vomiting B-NonOSE_AE
, O
fever B-NonOSE_AE
, O
and O
chills B-NonOSE_AE
. O

Physical O
examination O
revealed O
stomatitis B-NonOSE_AE
, O
erythematous B-NonOSE_AE
skin I-NonOSE_AE
rash I-NonOSE_AE
, O
neutropenia B-NonOSE_AE
, O
thrombocytopenia B-NonOSE_AE
, O
inflammation B-NonOSE_AE
of I-NonOSE_AE
the I-NonOSE_AE
esophagus I-NonOSE_AE
, O
stomach O
, O
and O
small O
bowel O
. O

Although O
this O
case O
was O
observed O
with O
5 O
% O
fluorouracil O
cream O
, O
it O
is O
unknown O
whether O
patients O
with O
profound O
DPD B-Not_AE_Candidate
enzyme I-Not_AE_Candidate
deficiency I-Not_AE_Candidate
would O
develop O
systemic B-NonOSE_AE
toxicity I-NonOSE_AE
with O
lower O
concentrations O
of O
topically O
applied O
fluorouracil O
. O

Applications O
to O
mucous B-NonOSE_AE
membranes I-NonOSE_AE
should O
be O
avoided O
due O
to O
the O
possibility O
of O
local O
inflammation I-NonOSE_AE
and O
ulceration O
. O

